Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immucell Corp (NQ: ICCC )

3.675 +0.025 (+0.68%)
Streaming Delayed Price Updated: 11:10 AM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,915
Open 3.650
Bid (Size) 3.670 (2)
Ask (Size) 3.780 (1)
Prev. Close 3.650
Today's Range 3.600 - 3.700
52wk Range 3.340 - 5.590
Shares Outstanding 7,741,864
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ICCC Stock Earnings: ImmuCell Beats Revenue for Q2 2024
ICCC stock results show that ImmuCell beat on revenue for the second quarter of 2024. 
Via InvestorPlace
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga

Performance

YTD
-26.50%
-26.50%
1 Month
-2.39%
-2.39%
3 Month
-10.37%
-10.37%
6 Month
-29.87%
-29.87%
1 Year
-29.87%
-29.87%

More News

Read More
ICCC Stock Earnings: ImmuCell Reported Results for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Via Benzinga
Exposures Product Safety
Earnings Scheduled For November 13, 2023
Via Benzinga
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For November 21, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For November 15, 2021
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
60 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.